A Cellular and Molecular Basis for the Selective Desmopressin-Induced ACTH Release in Cushing Disease Patients: Key Role of AVPR1b Receptor and Potential Therapeutic ImplicationsRaúl M. Luque, Justo P. Castaño, Alfonso Soto‐Moreno et al.|The Journal of Clinical Endocrinology & Metabolism|2013Cited by 81
Octreotide and pasireotide (dis)similarly inhibit pituitary tumor cells in vitroAlejandro Ibáñez‐Costa, Justo P. Castaño, Esther Rivero‐Cortés et al.|Journal of Endocrinology|2016Cited by 74
BIM-23A760 influences key functional endpoints in pituitary adenomas and normal pituitaries: molecular mechanisms underlying the differential response in adenomasAlejandro Ibáñez‐Costa, Raúl M. Luque, Laura M. López‐Sánchez et al.|Scientific Reports|2017Cited by 32
Somatotropinomas, But Not Nonfunctioning Pituitary Adenomas, Maintain a Functional Apoptotic RET/Pit1/ARF/p53 Pathway That Is Blocked by Excess GDNFEsther Díaz‐Rodriguez, Clara V. Álvarez, Ángela R. Garcia-Rendueles et al.|Endocrinology|2014Cited by 14
Differential in vitro response to octreotide and pasireotide in normal and tumoral primary pituitary cell culturesAlejandro Ibáñez‐Costa, Raúl M. Luque, Manuel D. Gahete et al.|Endocrine Abstracts|2014Cited by 0